Couverture de Sheppard's Health-e Law

Sheppard's Health-e Law

Sheppard's Health-e Law

De : Sheppard with Michael Orlando and Sara Shanti
Écouter gratuitement

À propos de ce contenu audio

 A podcast dedicated to the exciting, and sometimes explosive, interaction between technology and law in the health space, covering innovations that impact healthcare, like artificial intelligence, virtual reality and wearables. Hosted by Sheppard's Digital Health team, the Health-e Law podcast dives into the legal implications of health-tech you should know about and visits with trailblazing players in the industry.Copyright © 2026 Sheppard. All Rights Reserved. Politique et gouvernement
Les membres Amazon Prime bénéficient automatiquement de 2 livres audio offerts chez Audible.

Vous êtes membre Amazon Prime ?

Bénéficiez automatiquement de 2 livres audio offerts.
Bonne écoute !
    Épisodes
    • J.P. Morgan Healthcare 2026 and Beyond: Technology Adoption and Strategic Transformation Under Cost Pressure

      J.P. Morgan Healthcare 2026 and Beyond: Technology Adoption and Strategic Transformation Under Cost Pressure
      Feb 20 2026
      Welcome to Health-e Law, Sheppard's podcast exploring the fascinating health tech topics and trends of the day. In this episode, partner and host Michael Orlando welcomes Eric Newsom, partner and Transactions lead of Sheppard's national Healthcare industry team, to discuss key takeaways from the 2026 J.P. Morgan Healthcare Conference and explore what growing AI adoption, shifting reimbursement models and evolving macroeconomics mean for M&A and strategic partnerships. What we discuss in this episode: How the conference addressed the growing focus on AI-powered healthcare platforms. The key factors driving adoption of AI technologies across the healthcare industry. How providers and payers are adjusting their M&A and joint‑venture strategies amid shifting reimbursement models and evolving macroeconomic pressures. The top three priorities for healthcare leaders when advancing AI adoption and structuring strategic partnerships. Topics not covered at the conference that Eric would have liked to learn more about. About Eric Newsom Eric Newsom is a partner in the Corporate practice group in Sheppard's San Francisco office and serves as Transactions Lead of the firm's national Healthcare industry team. Eric's nationwide practice focuses on mergers and acquisitions, strategic joint ventures, corporate reorganizations, private equity and venture capital transactions, and corporate governance and compliance matters. Eric has represented buyers, sellers, investors, and intermediaries in numerous business combinations, buyouts, and investment transactions, with particular emphasis on the healthcare industry. In his healthcare and health technology practice, Eric advises on mergers, acquisitions, affiliations, comprehensive corporate reorganizations, multi-channel joint ventures, and private equity investment and disposition transactions. His experience spans for-profit, nonprofit, and government-owned hospital and provider systems; academic medical centers; health plans; physician groups; ambulatory and specialty service providers; and startup and growth-stage companies in the healthcare information technology sector. About Michael Orlando Michael Orlando is a partner in Sheppard's San Diego (Del Mar) office. He is team leader of the firm's Technology Transactions team, a member of the Life Sciences, Healthcare and Artificial Intelligence teams, and co-leader of the firm's Digital Health & Innovation team. Michael has more than 20 years of experience advising health technology companies, insurers, healthcare systems and providers, academic medical centers and research institutions, medical device manufacturers, and pharmaceutical and wellness companies on intellectual property and business transactions in key strategic areas, including EHR systems procurement and integration, telehealth, mobile health applications, clinical decision support technologies, artificial intelligence, data use, wearable devices, remote patient monitoring, and other medical devices, research and collaborations, patent licenses, software licenses, joint ventures, mergers and acquisitions, revenue cycle management, and other outsourcing transactions. Michael founded a software-as-a-service company before entering private practice and completed an in-house secondment at a publicly traded biotechnology company, an experience that informs his practical and business-focused approach to client engagements. Contact Info Eric Newsom Michael Orlando Thank you for listening! Don't forget to SUBSCRIBE to the show to receive new episodes delivered straight to your podcast player every month. If you enjoyed this episode, please help us get the word out about this podcast. Rate and Review this show on Apple Podcasts, Amazon Music, or Spotify. It helps other listeners find this show. This podcast is for informational and educational purposes only. It is not to be construed as legal advice specific to your circumstances. If you need help with any legal matter, be sure to consult with an attorney regarding your specific needs.
      Afficher plus Afficher moins
      19 min
    • J.P. Morgan Healthcare 2026 and Beyond: How Digital Innovation Shapes Healthcare M&A

      J.P. Morgan Healthcare 2026 and Beyond: How Digital Innovation Shapes Healthcare M&A
      Feb 9 2026
      Welcome to Health-e Law, Sheppard's podcast exploring the fascinating health tech topics and trends of the day. In this episode, partner and host Michael Orlando welcomes Amanda Zablocki, co-leader of Sheppard's Healthcare industry team, to explore key insights from the 2026 J.P. Morgan Healthcare Conference and discuss how digital innovation is transforming the healthcare M&A landscape What We Discuss in This Episode: How did buzzwords like AI and innovation shape conversations at this year's J.P. Morgan Healthcare Conference? What role does technology play in healthcare transactions? How is AI driving the next wave of consolidation among hospitals, health systems and health plans? What are the challenges and opportunities in integrating technology platforms during mergers and acquisitions? How does technology leadership influence whether an organization becomes a buyer, partner or target, and why is it critical to involve technology leaders early in the deal-making process? What is the impact of data assets, analytics platforms and AI-driven tools on healthcare transactions? How can organizations balance the cost of technology with their mission to serve patients and communities? What legal and regulatory considerations should healthcare organizations prioritize when adopting new technologies? About Amanda Zablocki Amanda Zablocki is a partner in the Corporate practice group in Sheppard's New York office and co-leader of the firm's Healthcare Industry team. A trusted legal and strategic advisor to healthcare organizations nationwide, she helps them to achieve their mission and goals while navigating a dynamic regulatory landscape. Large-scale, strategic transactions—mergers and acquisitions, joint ventures and strategic partnerships, and corporate reorganizations—are at the center of Amanda's practice. With extensive industry knowledge, a deep understanding of the key drivers and levers for success, and broad experience navigating the complex healthcare regulatory landscape, she helps clients close high-impact deals that transform healthcare. Amanda's clients include health plans and health insurers, hospital systems, academic medical centers, digital health and healthcare technology companies, pharmaceutical and life sciences companies, rare disease organizations, physician practices, management services organizations, value-based care organizations, and 501(c)(3) organizations. Having begun her career in commercial litigation, she brings a litigator's eye to managing risk in connection with disputes and advocating her clients' positions. Amanda co-founded Sheppard's Women in Healthcare Leadership Collaborative, an exclusive initiative that provides support to women professionals in the healthcare and life sciences industries. She is also co-founder and a board member of Hyper IgM Foundation, an organization committed to improving the treatment, quality of life and long-term outlook for children and adults living with Hyper IgM. About Michael Orlando Michael Orlando is a partner in Sheppard's San Diego (Del Mar) office. He is team leader of the firm's Technology Transactions team, a member of the Life Sciences, Healthcare and Artificial Intelligence teams, and co-leader of the firm's Digital Health team. Michael has more than 20 years of experience advising health technology companies, insurers, healthcare systems and providers, academic medical centers and research institutions, medical device manufacturers, and pharmaceutical and wellness companies on intellectual property and business transactions in key strategic areas, including EHR systems procurement and integration, telehealth, wearable devices, remote patient monitoring, mobile health applications, clinical decision support technologies, artificial intelligence, data use, research and collaborations, patent licenses, software licenses, joint ventures, mergers and acquisitions, revenue cycle management, and other outsourcing transactions. Before entering private practice, Michael founded a software-as-a-service company and completed an in-house secondment at a publicly traded biotechnology company, an experience that informs his practical and business-focused approach to client engagements. Contact Info Amanda Zablocki Michael Orlando Resources Women in Leadership Healthcare Collaborative (WHLC) Thank you for listening! Don't forget to SUBSCRIBE to the show to receive new episodes delivered straight to your podcast player every month. If you enjoyed this episode, please help us get the word out about this podcast. Rate and Review this show on Apple Podcasts, Amazon Music, or Spotify. It helps other listeners find this show. This podcast is for informational and educational purposes only. It is not to be construed as legal advice specific to your circumstances. If you need help with any legal matter, be sure to consult with an attorney regarding your specific needs.
      Afficher plus Afficher moins
      18 min
    • From AI to OBBBA: Healthcare Law Insights from the 2025 WHLC Leadership Summit with Amy Dilcher and Chi Huynh, WHLC Co-Chairs

      From AI to OBBBA: Healthcare Law Insights from the 2025 WHLC Leadership Summit with Amy Dilcher and Chi Huynh, WHLC Co-Chairs
      Dec 4 2025
      Welcome to Health-e Law, Sheppard Mullin's podcast exploring the fascinating health tech topics and trends of the day. In this episode, Michael Orlando welcomes Amy Dilcher and Chi Huynh, co-chairs of Sheppard Mullin's Women in Healthcare Leadership Collaborative (WHLC), to discuss key takeaways from the 2025 WHLC Leadership Summit. What We Discussed in this Episode: What is WHLC, and what is its mission? What is the purpose of the annual leadership summit? What was the theme for 2025? What topics were discussed during this year's summit panels? What were the key takeaways regarding healthcare transactions, AI, reimbursement and regulatory changes, and telehealth? Looking ahead to 2026, what's on WHLC's agenda? How can the annual summit help advance women in healthcare leadership? What do you see as the key drivers that help support women in leadership? How does the WHLC summit encourage collaboration? What is Legal Bridge Services, and what drove its creation? About Amy Dilcher Amy Dilcher is a partner in the Corporate Practice Group in Sheppard Mullin's Washington, D.C. office and Co-Chair of WHLC. With more than 25 years in the healthcare industry and a prior career as an oncology nurse, Amy's dual understanding of the clinical and legal aspects of healthcare enables her to deliver practical, tailored solutions that balance business goals with regulatory compliance. Amy advises hospitals, health systems, and private equity–backed organizations on strategic affiliations, hospital and physician transactions, regulatory compliance, and operational risk. Her background as Chief Legal Officer and General Counsel enables her to offer practical guidance that aligns legal strategy with business and clinical priorities. Her practice includes structuring and negotiating complex healthcare transactions, developing compliance programs, and supporting post-transaction integration. She also provides ongoing counsel to leadership teams navigating regulatory and operational challenges. Amy is certified as a Yellow Belt in Legal Process Improvement and Project Management through Legal Lean Sigma, and she assists clients in strengthening legal operations, improving workflow efficiency, and enhancing organizational performance. About Chi Huynh Chi Huynh is a partner in the Corporate Practice Group in Sheppard Mullin's Century City office and Co-Chair of WHLC. Her practice focuses on healthcare transactions, compliance, mergers and acquisitions, and corporate governance. Chi represents physician groups, independent physician associations, hospitals and affiliated foundations, nonprofit health organizations, pharmacies, and other healthcare entities in mergers and acquisitions, operational matters, contracting, and general corporate counsel work. She also handles healthcare regulatory issues involving information privacy, the corporate practice of medicine, anti-kickback rules, and Stark Law considerations. She also advises public and private companies, private equity firms, and strategic investors on mergers and acquisitions, joint ventures, investment structures, and corporate governance. Her work spans a range of industries, including semiconductor, food and beverage, specialty manufacturing, entertainment, energy, and renewable energy. Before joining Sheppard Mullin, Chi served as Associate General Counsel at IPC Healthcare, Inc., where she led a team responsible for negotiating, documenting, and closing more than 35 acquisitions across multiple states. About Michael Orlando Michael Orlando is a corporate and intellectual property transactions attorney in Sheppard Mullin's San Diego (Del Mar) office, where he leads the firm's Technology Transactions Team and is a member of the Life Sciences and Healthcare teams. Michael advises technology companies on the development, commercialization, and procurement of their products. His expertise covers a broad spectrum of transactions, including licensing, outsourcing, joint ventures, mergers and acquisitions, collaborations, and strategic partnerships. By integrating corporate and intellectual property law, Michael structures deals that align his clients' legal, technical, and business objectives. His practice serves a diverse range of industries—from biotechnology and digital health to aerospace and automotive technologies, with a particular focus on electric, autonomous, and connected vehicle systems. He represents a wide array of clients, from early-stage startups to Fortune 500 companies. Before entering private practice, Michael founded a software-as-a-service company and completed an in-house secondment at a publicly traded biotechnology company, an experience that informs his practical and business-focused approach to client engagements. Contact Info Amy Dilcher Chi Huynh Michael Orlando Resources Women in Leadership Healthcare Collaborative (WHLC) Thank you for listening! Don't forget to SUBSCRIBE to the show to receive new ...
      Afficher plus Afficher moins
      14 min
    Aucun commentaire pour le moment